229 related articles for article (PubMed ID: 30111636)
1. The Antinociceptive and Anti-Inflammatory Properties of the
Quadri M; Bagdas D; Toma W; Stokes C; Horenstein NA; Damaj MI; Papke RL
J Pharmacol Exp Ther; 2018 Nov; 367(2):203-214. PubMed ID: 30111636
[TBL] [Abstract][Full Text] [Related]
2. Allosteric Agonism of
Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
[TBL] [Abstract][Full Text] [Related]
3. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
[TBL] [Abstract][Full Text] [Related]
5. A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties.
Gill JK; Dhankher P; Sheppard TD; Sher E; Millar NS
Mol Pharmacol; 2012 May; 81(5):710-8. PubMed ID: 22328718
[TBL] [Abstract][Full Text] [Related]
6. Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.
Pałczyńska MM; Jindrichova M; Gibb AJ; Millar NS
Mol Pharmacol; 2012 Nov; 82(5):910-7. PubMed ID: 22874415
[TBL] [Abstract][Full Text] [Related]
7. Allosterically Potentiated
Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
[TBL] [Abstract][Full Text] [Related]
8. Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
Papke RL; Stokes C; Damaj MI; Thakur GA; Manther K; Treinin M; Bagdas D; Kulkarni AR; Horenstein NA
Br J Pharmacol; 2018 Jun; 175(11):1838-1854. PubMed ID: 28477386
[TBL] [Abstract][Full Text] [Related]
9. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
[TBL] [Abstract][Full Text] [Related]
10. Differential Activation and Desensitization States Promoted by Noncanonical
Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL
J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397
[TBL] [Abstract][Full Text] [Related]
11. Dissection of N,N-diethyl-N'-phenylpiperazines as α7 nicotinic receptor silent agonists.
Quadri M; Papke RL; Horenstein NA
Bioorg Med Chem; 2016 Jan; 24(2):286-93. PubMed ID: 26707847
[TBL] [Abstract][Full Text] [Related]
12. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
[TBL] [Abstract][Full Text] [Related]
13. The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.
Papke RL; Horenstein NA; Kulkarni AR; Stokes C; Corrie LW; Maeng CY; Thakur GA
J Biol Chem; 2014 Feb; 289(7):4515-31. PubMed ID: 24362025
[TBL] [Abstract][Full Text] [Related]
14. The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
Bagdas D; Targowska-Duda KM; López JJ; Perez EG; Arias HR; Damaj MI
Anesth Analg; 2015 Nov; 121(5):1369-77. PubMed ID: 26280585
[TBL] [Abstract][Full Text] [Related]
15. Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of
Papke RL; Garai S; Stokes C; Horenstein NA; Zimmerman AD; Abboud KA; Thakur GA
Mol Pharmacol; 2020 Oct; 98(4):292-302. PubMed ID: 32690627
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
17. Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.
Horenstein NA; Papke RL; Kulkarni AR; Chaturbhuj GU; Stokes C; Manther K; Thakur GA
J Biol Chem; 2016 Mar; 291(10):5049-67. PubMed ID: 26742843
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-7 nicotinic acetylcholine receptor positive allosteric modulator on lipopolysaccharide-induced neuroinflammatory pain in mice.
Abbas M; Rahman S
Eur J Pharmacol; 2016 Jul; 783():85-91. PubMed ID: 27154173
[TBL] [Abstract][Full Text] [Related]
19. Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
Newcombe J; Chatzidaki A; Sheppard TD; Topf M; Millar NS
Mol Pharmacol; 2018 Feb; 93(2):128-140. PubMed ID: 29196491
[TBL] [Abstract][Full Text] [Related]
20. Macroscopic and Microscopic Activation of
Quadri M; Garai S; Thakur GA; Stokes C; Gulsevin A; Horenstein NA; Papke RL
Mol Pharmacol; 2019 Jan; 95(1):43-61. PubMed ID: 30348894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
